• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 0.00% 21.0¢

PHARMAUST LIMITED

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAA
PAA Chart
3 4 5
14:20 295 82K
14:20 Last post  Buckland Comments Created with Sketch.  295  Views Created with Sketch.  82K 
PAA
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
13 14 15
10:18 895 235K
10:18 Last post  Bunter62 Comments Created with Sketch.  895  Views Created with Sketch.  235K 
PAA
Pharmaust - Media & News
19/07/24 57 21K
Metals & Mining SECTOR NEWS

Infini Resources continues winning streak having identified major fault system and magnetic anomalies

I88
22 Jul 2024
INFINI RESOURCES LIMITED
19/07/24 Last post  Moreforme Comments Created with Sketch.  57  Views Created with Sketch.  21K 
PAA 18/07/24 64 16K
18/07/24 Last post  mc3456 Comments Created with Sketch.  64  Views Created with Sketch.  16K 
PAA 18/07/24 81 22K
18/07/24 Last post  Nickporthcawl Comments Created with Sketch.  81  Views Created with Sketch.  22K 
PAA 15/07/24 35 8.9K
15/07/24 Last post  Jakjazz Comments Created with Sketch.  35  Views Created with Sketch.  8.9K 
PAA
Company Analysis - Morgans
10/07/24 19 8.0K
10/07/24 Last post  ma420 Comments Created with Sketch.  19  Views Created with Sketch.  8.0K 
PAA
Share Purchase Plan (SPP)
06/07/24 12 5.8K
06/07/24 Last post  Bunter62 Comments Created with Sketch.  12  Views Created with Sketch.  5.8K 

See All Discussions arrow Created with Sketch.

Timeline

Investor Update - HEALEY ALS Platform Trial Selection
15 Jul 08:49
 
Monepantel Selected for Entry into HEALEY ALS Platform Trial
15 Jul 08:42
 
Investor Briefings & Webinar Notice
08 Jul 11:25
 
PharmAust Granted SME Status by European Medicines Agency
01 Jul 08:52
 
Section 708A Cleansing Statement
28 Jun 09:37
 
Notification regarding unquoted securities - PAA
28 Jun 09:28
 
View More arrow Created with Sketch.
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 20.5¢ $106.7K 516.1K

Buyers (Bids)

No. Vol. Price($)
2 24033 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 55077 2
View Market Depth
Last trade - 15.22pm 22/07/2024 (20 minute delay) ?
Last
21.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
21.0¢ 21.0¢ 20.5¢ 342599
Last updated 15.22pm 22/07/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.